MEDIANA Co.,Ltd
Financials
Valuation Metrics
MEDIANA Co.,Ltd's Market Cap is ₩1467B. At end of 2025 it was ₩1705B. Ranked #988 of 2,410 in KR market (top 41%), #485 of 1,631 on KOSDAQ (top 30%), #31 of 94 in Health Care Equipment & Services (top 33%) by Market Cap.
Investment Metrics(as of 2026-11-02)
| Metric | Value | Rank |
|---|---|---|
| Size | ||
| Market Cap | 146.74B KRW | KR#988/2,410 Sec#31/94 |
| Revenue | 71.45B KRW | KR#1,612/2,410 Sec#46/94 |
| Net Income | 9.62B KRW | KR#987/2,410 Sec#26/94 |
| Total Assets | 146.84B KRW | KR#1,520/2,410 Sec#44/94 |
| Net Assets | 135.43B KRW | KR#1,201/2,410 Sec#34/94 |
| Employees | 174 | KR#1,194/2,410 Sec#36/94 |
| Value | ||
| P/E | 15.25x | KR#1,092/2,410 Sec#34/94 |
| P/B | 1.08x | KR#1,576/2,410 Sec#49/94 |
| PEG | 0.07x | KR#361/2,410 Sec#16/94 |
| P/S | 2.05x | KR#1,850/2,410 Sec#53/94 |
| EV/EBITDA | 15.36x | KR#891/2,410 Sec#29/94 |
| FCF Yield | 3.36% | KR#969/2,410 Sec#28/94 |
| Profitability | ||
| ROE | 7.10% | KR#869/2,410 Sec#34/94 |
| ROA | 6.55% | KR#565/2,410 Sec#29/94 |
| Op. Margin | 11.22% | KR#460/2,410 Sec#26/94 |
| Revenue Growth | 23.49% | KR#486/2,410 Sec#25/94 |
| Earnings Growth | 223.02% | KR#225/2,410 Sec#12/94 |
| Financial Health | ||
| Debt Ratio | 8.42% | KR#104/2,410 Sec#7/94 |
| Total Debt | 3.26B KRW | KR#1,845/2,410 Sec#66/94 |
| FCF | 4.94B KRW | KR#907/2,410 Sec#25/94 |
| Cash | 26.94B KRW | KR#1,068/2,410 Sec#27/94 |
| Net Debt/EBITDA | -2.96x | KR#162/2,410 Sec#4/94 |
| Dividend | ||
| Div. Growth | -49.99% | KR—/2,410 Sec—/94 |
| Performance | ||
| 1Y Return | 48.59% | KR#191/2,410 Sec#4/94 |
| 1M Return | -22.34% | KR#2,067/2,410 Sec#89/94 |
| From 52W High | -73.34% | KR#2,176/2,410 Sec#86/94 |
| 1Y MDD | -74.59% | KR#2,132/2,410 Sec#86/94 |
| Trading | ||
| Volume | 51,596 shares | KR#1,087/2,410 Sec#43/94 |
| Trading Value | 401.0M KRW | KR#978/2,410 Sec#35/94 |
| Foreign Own. | 4.94% | KR#864/2,410 Sec#27/94 |
| Per Share | ||
| EPS | 517 KRW | KR#982/2,410 Sec#25/94 |
| BPS | 7,282 KRW | KR#1,212/2,410 Sec#26/94 |
Company Info
Established in 1995 for medical device manufacturing and sales, the company was listed on KOSDAQ in 2014 and is preparing for AI medical business with its parent company, Selvas AI. It primarily produces patient monitoring devices and defibrillators under ODM and its own brand, while expanding into new business areas such as body composition analyzers and PICC catheters. The company secures a stable sales structure through export contracts with global companies and pursues technology platform innovation through participation in medical device exhibitions and R&D investment. Mediana, established in 1995, is headquartered in Wonju City, Gangwon-do.